These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2083992)

  • 21. Measles outbreak in a refugee settlement in Calais, France: January to February 2016.
    Jones G; Haeghebaert S; Merlin B; Antona D; Simon N; Elmouden M; Battist F; Janssens M; Wyndels K; Chaud P
    Euro Surveill; 2016; 21(11):30167. PubMed ID: 27020578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measles mortality and vaccine efficacy in rural West Africa.
    Hull HF; Williams PJ; Oldfield F
    Lancet; 1983 Apr; 1(8331):972-5. PubMed ID: 6132278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines.
    Markowitz LE; Sepulveda J; Diaz-Ortega JL; Valdespino JL; Albrecht P; Zell ER; Stewart J; Zarate ML; Bernier RH
    N Engl J Med; 1990 Mar; 322(9):580-7. PubMed ID: 2304505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Measles outbreaks in the Bern canton].
    Maurer AM; Mühlemann K
    Schweiz Med Wochenschr; 1998 Feb; 128(9):317-22. PubMed ID: 9544458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sub-national variation in measles vaccine coverage and outbreak risk: a case study from a 2010 outbreak in Malawi.
    Kundrick A; Huang Z; Carran S; Kagoli M; Grais RF; Hurtado N; Ferrari M
    BMC Public Health; 2018 Jun; 18(1):741. PubMed ID: 29902976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of low measles vaccination coverage in children living in an endemic area.
    Lo Vecchio A; Cambriglia MD; Fedele MC; Basile FW; Chiatto F; Miraglia Del Giudice M; Guarino A
    Eur J Pediatr; 2019 Feb; 178(2):243-251. PubMed ID: 30430239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of measles in Blantyre, Malawi: analyses of passive surveillance data from 1996 to 1998.
    Yamaguchi S; Dunga A; Broadhead RL; Brabin BJ
    Epidemiol Infect; 2002 Oct; 129(2):361-9. PubMed ID: 12403112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New measles vaccination schedules in the European countries?
    Allam MF
    J Prev Med Hyg; 2014 Mar; 55(1):33-4. PubMed ID: 25916031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measles vaccine efficacy during an outbreak in a highly vaccinated population: incremental increase in protection with age at vaccination up to 18 months.
    De Serres G; Boulianne N; Meyer F; Ward BJ
    Epidemiol Infect; 1995 Oct; 115(2):315-23. PubMed ID: 7589271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergency measles control activities--Darfur, Sudan, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Oct; 53(38):897-9. PubMed ID: 15457146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Must we expect an epidemic of measles in the near future in Southern Tyrol?].
    Kreidl P; Morosetti G
    Wien Klin Wochenschr; 2003; 115 Suppl 3():55-60. PubMed ID: 15508782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced childhood mortality after standard measles vaccination at 4-8 months compared with 9-11 months of age.
    Aaby P; Andersen M; Sodemann M; Jakobsen M; Gomes J; Fernandes M
    BMJ; 1993 Nov; 307(6915):1308-11. PubMed ID: 8257884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two doses of measles vaccine: are some states in India ready for it?
    John S; Sanghi S; Prasad S; Bose A; George K
    J Trop Pediatr; 2009 Aug; 55(4):253-6. PubMed ID: 18799515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measles vaccine efficacy during an epidemic in 1998 in the highly vaccinated population of Poland.
    Janaszek W; Gay NJ; Gut W
    Vaccine; 2003 Jan; 21(5-6):473-8. PubMed ID: 12531646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measles epidemiology and outbreak response immunization in a rural community in Peru.
    Sniadack DH; Moscoso B; Aguilar R; Heath J; Bellini W; Chiu MC
    Bull World Health Organ; 1999; 77(7):545-52. PubMed ID: 10444877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measles vaccine efficacy in children previously vaccinated at 12 months of age.
    Marks JS; Halpin TJ; Orenstein WA
    Pediatrics; 1978 Dec; 62(6):955-60. PubMed ID: 733423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measles outbreak in 31 schools: risk factors for vaccine failure and evaluation of a selective revaccination strategy.
    Yuan L
    CMAJ; 1994 Apr; 150(7):1093-8. PubMed ID: 8137189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measles in Jordan: a prototype of the problems with measles in developing countries.
    Khuri-Bulos NA
    Pediatr Infect Dis J; 1995 Jan; 14(1):22-6. PubMed ID: 7715984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measles control in developing and developed countries: the case for a two-dose policy.
    Tulchinsky TH; Ginsberg GM; Abed Y; Angeles MT; Akukwe C; Bonn J
    Bull World Health Organ; 1993; 71(1):93-103. PubMed ID: 8440043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.